The CDC has identified cases of a rare and deadly fungal meningitis in Indiana and several other states. According to the Associated Press, the FDA has identified the New England Compounding Center in Framingham, Massachusetts as the pharmacy that supplied the steroid, known as methylprednisolone acetate, that was contaminated with a fungus.
Cases have been reported in Tennessee, Virginia, Maryland, Florida, North Carolina, Indiana, Michigan, Minnesota and Ohio.
According to a report published in USA Today, Dr. Benjamin Park, a medical officer at the CDC’s mycotic diseases branch, states that it is “possible that if patients with infection are identified soon and put on appropriate anti-fungal therapy, lives may be saved.”
For additional information, see this release issued by the Indiana State Department of Health.